Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BioVersys AG is a Swiss biopharmaceutical company based in Basel. It develops novel antibiotics and compounds targeting antimicrobial resistance, addressing hard-to-treat bacterial infections such as tuberculosis and hospital-acquired infections.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BioVersys is scheduled to report its next quarterly earnings on 09/09/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.